Abstract
Venous malformations are often detected at birth and progressively increase in size if not treated. They can have severe aesthetic and functional consequences. Our purpose is to evaluate therapeutic results with Ethibloc. From 1982 to 1994, we have been using Ethibloc injections under fluoroscopic control in a group of 421 patients with malformations in cervicofacial veins. The diagnosis was made on the basis of clinical examinations as well as by using CT and MRI. In addition, 40 patients had a diagnostic angiogram. The therapeutic procedure consisted of direct puncture and opacification of venous the basis of lakes before injection of Ethibloc. Two hundred patients have been analyzed. In 139 patients treated with Ethibloc alone, the venous malformations were reduced significantly in size in 64%, while we obtained good results in 67% of the 61 patients treated with a combined procedure (Ethibloc followed by surgical excision). In those, Ethibloc effectively prevented extensive blood loss during surgery and delineated the malformations. Minor complications occurred such as fever or aseptic superficial abscesses. Ethibloc is safe, has no neurotoxicity, is efficient can be repeated many times and facilitates surgery. It must be used as the therapy of choice in venous malformations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Enjolras O, Riche MC, Mulliken JB, Merland JJ (1990) Atlas des hémangiomes et malformations vasculaires. Medsi McGraw-Hill, Paris, pp 123–153
Mulliken JB, Young AE (1988) Vascular birthmarks. Saunders, Philadelphia 317–324
Burrows PE, Mulliken JB, Fellows KE et al (1983) Childhood hemangiomas and vascular malformations, arteriographic differentiation AJR 141: 483–488
Klap P, Hadjean E, Negrier B et al (1987) Les angiomes capillaroveineux temporomassétérins. Ann Otolaryngol 104: 433–439
Merland JJ, Natali J (1976) Superselective arteriography and therapeutic embolization for vascular malformations. J Cardiovasc Surg 17: 405–472
Herbretau D, Slaba S, Aymard A, Houdart E, Guichard JP, Gobin P, Reizine D, Merland JJ (1993) Role of direct percutaneous embolotherapy in the management of superficial vascular malformations. In: Vascular Medicine, Excerpta Medica. Elsevier, Amsterdam 619–622
Riche MC, Hadjean E, Tran Ba Huy P et al (1983) The treatment of capillarovenous malformations using a new fibrosing agent. Plast Reconstr Surg 71: 607–612
Riche MC, Merland JJ (1988) Embolization of vascular malformations. In: Mulliken JB (ed) Vascular Birthmarks. Saunders, Philadelphia, pp 436–453
Enjolras O, Mulliken JB (1993) The current management of vascular birthmarks. Pediatr Dermatol 10: 4311–4333
Yakes W, Haas DK, Parker SH et al (1989) Symptomatic vascular malformations: Ethanol embolotherapy. Radiology 170: 1059–1066
Lasjaunias P, Berenstein A. Surgical Neuroangiography, vol. 2. Endovascular Treatment of craniofacial lesions. Springer Berlin Heidelberg New York
Herbreteau D, Riche MC, Enjolras O, Khayatta M, Lemarchand Venencie F, Borsik M, Brette MD, Reizine D, Merland JJ (1993) Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients. Int Angiol 12: 34–39
Duffy DM (1991) Sclerotherapy: Broader Horizons. J Cutan Aging Cosmet Dermatol 1: 263–268
Breviere GM, Bonnevalle M, Pruvo JP, Besson R, Marache P, Herbaux P, Debenguy P (1993) Use of Ethibloc in the treatment of cystic and venous angiomas in children 19 cases. Eur Pediatr Surg 3: 166–170
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herbreteau, D., Enjolras, O., Gelbert, F. et al. The current management of cervico-cephalic venous malformations. Pediatr Surg Int 11, 304–307 (1996). https://doi.org/10.1007/BF00497798
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00497798